Passage Bio, Inc. - PASG Company Short-Term Debt

Public company logo of Passage Bio, Inc. (PASG)

Passage Bio, Inc. (PASG) aims to secure a dominant position in the treatment of rare CNS pathologies by developing AAV vectors. The strategy relies on a partnership with the University of Pennsylvania and the implementation of robotic systems in laboratories. The short-term borrowing metric reflects obligations of up to one year, with the indicator currently standing at 0.00, which helps assess the issuer's current credit stability.

Passage Bio Corp (PASG): Current Liabilities from 07/04/2022 to 10/28/2026

Passage Bio Inc. - analytical breakdowns and key metrics (PASG)

- price and consensus price forecast:
Price Chart Passage Bio Corp|PASG - Fair Value Consensus
- market capitalization data:
Market Value Passage Bio, Inc.|PASG - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Passage Bio|PASG - Net Asset Value|Market Capitalization to Book Value Ratio passagebio.com|PASG - Company Total Assets
- debt and liquidity data:
Debt to Equity Passage Bio, Inc.|PASG - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Passage Bio Corp|PASG - Company Total Debt Obligations|Debts to Book Capitalization Passage Bio, Inc.|PASG - Company Long-Term Debts|Company Short-Term Debts Passage Bio
Analysis of all company metrics:passagebio.com (PASG)
Product sample of Passage Bio Corp

To assess the fundamental stability of Passage Bio, Inc. (PASG), it is essential to weigh its long-term potential to monopolize the orphan gene therapy market against its current liquidity. By analyzing short-term debt financing, an investor determines the volume of obligations maturing within one year, which allows for an assessment of the developer's solvency and the risk of cash flow gaps in the absence of operational cash flow.

Competitors of Passage Bio, Inc. (PASG)

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|AXSM (Axsome Corp) - Short-Term Debt|Company Short-Term Debt ACADIA Pharmaceuticals ACAD|Current Liabilities xenon-pharma.com|Company Short-Term Debts VKTX|Company Short-Term Debts SUPN (Supernus Pharmaceuticals, Inc.)|Company Short-Term Debt CPRX|Denali Corp - Short-Term Debt Volume|Company Short-Term Debt HRMY (Harmony Biosciences)|BHVN - Short-Term Debt Volume|AMLX: Company Short-Term Debts|Trevi Therapeutics Inc (TRVI) - Company Short-Term Debts|Praxis Medicines - Company Short-Term Debts|Short-Term Indebtedness Anavex Life Sciences Corp|CeriBell, Inc. - Company Short-Term Debts|Short-Term Debt Prothena Corporation plc PRTA|Company Current Liabilities Alector|Company Short-Term Loans and Borrowings Annexon Biosciences ANNX|OMER - Company Short-Term Debts|NGNE - Company Short-Term Debt|AC Immune - Company Short-Term Debts|VYGR (voyagertherapeutics.com) - Short-Term Debt Volume|Company Short-Term Debt NMRA (Neumora Therapeutics, Inc.)|Short-Term Debt Scilex Holding (SCLX)|Tevogen Bio Holdings, Inc. (TVGN) - Company Current Liabilities|Company Short-Term Loans and Borrowings alphacognition.com (ACOG)|Company Short-Term Debts CGTX|inhibikase.com - Short-Term Debt Volume|Cassava Sciences (SAVA) - Company Short-Term Debt|ASRT - Company Short-Term Indebtedness|COYA (coyatherapeutics.com) - Company Short-Term Debts|Company Current Liabilities Vistagen|OVID: Company Current Liabilities|Short-Term Debt Volume ABOS|CRVO - Company Short-Term Debt|Current Liabilities alteritytherapeutics.com (ATHE)|Company Short-Term Debts CLNN (Clene)|PepGen Inc - Company Short-Term Debts|Company Short-Term Debt JUNS (Jupiter Neurosciences)|RLMD - Short-Term Debt Volume|Company Short-Term Debts ANVS (Annovis Bio)|GRCE (Grace Therapeutics) - Short-Term Indebtedness|Company Short-Term Debt Firefly Neuroscience Inc (AIFF)|Company Short-Term Indebtedness ANEW Medical, Inc.|NeuroSense Therapeutics - Company Short-Term Debts|Short-Term Debt revivapharma.com RVPH|Company Current Liabilities MTVA (MetaVia)|NeurAxis Inc. - Company Short-Term Debts|Company Short-Term Debt Helius Medical Technologies Inc. (HSDT)|NEUP: Company Short-Term Loans and Borrowings|Company Short-Term Debt NERV|ATHA (athira.com) - Short-Term Debt|Company Short-Term Debt Addex Therapeutics Ltd ADXN|Current Liabilities Alzamend|Company Short-Term Debts CYCN|Company Short-Term Debts PTIX (protagenic.com)|Company Short-Term Debt KTTA|Cortigent Inc - Short-Term Debt Volume|Company Short-Term Debt ATXI (Avenue Therapeutics, Inc.)|BCLI - Short-Term Debt Volume|CARA: Company Short-Term Debts|Chromocell (CHRO) - Company Short-Term Debts|Eliem Therapeutics, Inc. - Company Short-Term Debts|Short-Term Indebtedness Intra-Cellular|Longboard Pharmaceuticals, Inc. - Company Short-Term Debts|Short-Term Debt Marinus Pharmaceuticals Inc MRNS|Company Current Liabilities NKGen|Company Short-Term Loans and Borrowings NeuroBo Pharma NRBO|SAGE - Company Short-Term Debts|SNPX - Company Short-Term Debt|Trevena - Company Short-Term Debts|VIGL (Vigil Neuroscience, Inc.) - Short-Term Debt Volume|Company Short-Term Debt WENA (Anew Medical, Inc.)|Short-Term Debt Cerevel Corp (CERE)